OakChart

Ultragenyx Pharmaceutical Inc

RAREHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 2:25 PM ET

16.75+0.61 (3.78%)
2026-11-11 20:26 CET
Market cap
1,645.05 USD m
Revenue, TTM
730.00 USD m
Net income, TTM
-524.00 USD m
Free cash flow, TTM
-441.77 USD m
EPS diluted, TTM
-5.19
P/E
-
Compare

Price

RARE against its 20, 50 and 200-day averages
2050200beatmiss
20.0030.0013.6M27.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26RAREclose 16.7520-day 16.0850-day 15.47200-day 22.6116.7552w low

58.0% under the 52-week high of 39.89 on 8 Dec 2025. 52-week low 12.73 on 16 Sep 2026. Last 15 sessions, 16.9% high to low

Profile

RARE
52-week range, 15% of the way up
12.7339.89

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

IndexRUT
Employees1371
IPOJan 31, 2014
Beta0.35
ATR, 14d0.92
Rel volume0.33
Short float25.33%
Insider own8.51%
Inst own109.91%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.71B
Enterprise Value2.63B
Income-524.00M
Sales730.00M
Book/sh-3.69
Cash/sh2.69
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1371
IPOJan 31, 2014

Ratios

P/E-
Forward P/E82.25
PEG-
P/S2.34
P/B-
P/C6.23
P/FCF-
EV/EBITDA-
EV/Sales3.60
Quick Ratio1.25
Current Ratio1.40
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)-5.19
EPS next Y0.20
EPS next Q2.19
EPS this Y72.82%
EPS next Y112.85%
EPS next 5Y-
EPS past 3/5Y16.78% -13.72%
Sales past 3/5Y22.81% 19.95%
EPS Y/Y TTM12.63%
Sales Y/Y TTM15.76%
EPS Q/Q36.09%
Sales Q/Q8.17%
EarningsNov 03 AMC
EPS/Sales Surpr.-5.42% -5.20%

Ownership

Insider Own8.51%
Insider Trans-0.39%
Inst Own109.91%
Inst Trans1.71%
ROA-44.08%
ROE-656.54%
ROIC-71.78%
Gross Margin78.25%
Oper. Margin-64.11%
Profit Margin-71.78%
SMA204.16%
SMA508.25%
SMA200-25.91%
Trades-

Technical

Shs Outstand101.90M
Shs Float93.25M
Short Float25.33%
Short Ratio5.32
Short Interest23.62M
52W High39.89 -58.01%
52W Low12.73 31.58%
Volatility7.71% 5.44%
ATR (14)0.92
RSI (14)54.05
Beta0.35
Rel Volume0.33
Avg Volume4.44M
Volume1,125,041

Performance

Perf Week-2.39%
Perf Month12.27%
Perf Quarter-36.50%
Perf Half Y-36.70%
Perf YTD-27.17%
Perf Year-49.62%
Perf 3Y-51.99%
Perf 5Y-79.54%
Perf 10Y-79.59%
Recom2.05
Target Price25.35
Prev Close16.14
Price16.75
Change %3.78%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 15, 2026InitiatedUUBSNeutral$16-4.5%
Sep 03, 2026DowngradeWWilliam BlairOutperform → Mkt Perform
Sep 03, 2026DowngradeWWells FargoOverweight → Equal Weight$18+7.5%
Sep 03, 2026DowngradeRRobert W. BairdOutperform → Neutral$16-4.5%
Sep 03, 2026DowngradeJJP MorganOverweight → Neutral$36+114.9%
Sep 03, 2026DowngradeEEvercore ISIOutperform → In-line$16-4.5%
Sep 03, 2026DowngradeBBofA SecuritiesBuy → Neutral
Mar 24, 2026DowngradeGGoldmanBuy → Neutral$25+49.3%
Oct 20, 2025InitiatedWWells FargoOverweight$65+288.1%
Jul 28, 2025ResumedHH.C. WainwrightBuy$80+377.6%

Peers

Mkt cap
TickerCompanyMkt cap
BMRNBiomarin Pharmaceutical Inc11.20B
PTCTPTC Therapeutics Inc5.38B
IONSIonis Pharmaceuticals Inc4.79B
MIRMMirum Pharmaceuticals Inc6.16B
MREOMereo Biopharma Group Plc ADR49.19M
ASNDAscendis Pharma A/S16.93B
SRPTSarepta Therapeutics Inc1.79B
RYTMRhythm Pharmaceuticals Inc7.97B
QUREuniQure NV1.69B
KRYSKrystal Biotech Inc9.17B

Insider trading

latest 14 of 43
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Horn HowardChief Financial OfficerOct 15 '26Sale15.277,066107,89889,229Oct 19 01:48 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerSep 15 '26Sale13.571,28317,41067,863Sep 15 06:57 PM
THEODORE HUIZENGAOfficerSep 15 '26Proposed Sale13.611,28317,462Sep 15 04:33 PM
Huizenga Theodore AlanSVP, Chief Accounting OfficerSep 03 '26Sale13.991612,25269,146Sep 08 12:29 PM
Parschauer Karah HerdmanEVP and Chief Legal OfficerAug 03 '26Sale24.921,90047,34892,562Aug 04 03:15 PM
Horn HowardChief Financial OfficerAug 03 '26Sale24.924,696117,02496,295Aug 04 03:13 PM
HOWARD HORNOfficerAug 03 '26Proposed Sale24.924,696117,024Aug 03 04:18 PM
Horn HowardChief Financial OfficerJul 01 '26Sale33.134,698155,645100,991Jul 06 03:37 PM
HOWARD HORNOfficerJul 01 '26Proposed Sale33.134,698155,645Jul 01 04:19 PM
Sanders Corazon (Corsee) D.DirectorJun 15 '26Sale25.052,00050,10021,095Jun 15 06:50 PM
Parschauer Karah HerdmanEVP and Chief Legal OfficerJun 15 '26Sale24.621,89946,75394,462Jun 15 06:46 PM
KARAH PARSCHAUEROfficerJun 15 '26Proposed Sale24.353,79992,506Jun 15 04:50 PM
CORAZON D. SANDERSDirectorJun 15 '26Proposed Sale25.052,00050,100Jun 15 04:12 PM
Horn HowardChief Financial OfficerJun 01 '26Sale23.774,653110,602105,689Jun 01 07:11 PM

Held by

AUM
TickerCompanyAUM
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IBBiShares Biotechnology ETFAUM: 11.36B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWNiShares Russell 2000 Value ETFAUM: 14.10B

News

latest 14 of 99

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-03-1.160-1.100-1.160173182.4920
2026Q22026-08-04-0.900-1.218-0.903214183.0819
2026Q12026-05-05-1.840-1.488-1.839136158.1917
2025Q42026-02-12-1.290-1.093-1.291207198.619
2025Q32025-11-04-1.810-1.234-1.808159.93166.8319
2025Q22025-08-05-1.170-1.297-1.168166.5162.0119
2025Q12025-05-06-1.570-1.598-1.569139.29143.8218
2024Q42025-02-13-1.390-1.309-1.394164.88151.8619
2024Q32024-11-05-1.400-1.484-1.398139.49135.2817
2024Q22024-08-01-1.520-1.661-1.520147.03123.218
2024Q12024-05-02-2.030-1.747-2.025108.83116.0319
2023Q42024-02-15-1.520-1.707-1.519127.39119.3818
2023Q32023-11-02-2.230-2.077-2.22898.05109.617
2023Q22023-08-03-2.250-2.090-2.254108.31104.8117
2023Q12023-05-04-2.330-1.992-2.330100.5104.7116
2022Q42023-02-16-2.160-2.135-2.164103.35105.1118

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-7.120-6.938-7.118103.71100.42
2020FY-3.070-3.794-3.066271.03250.02
2021FY-6.700-6.254-6.697351.41351.78
2022FY-10.120-9.922-10.118363.33361.74
2023FY-8.250-8.372-8.249434.25428.63
2024FY-6.290-6.191-6.287560.23547.6
2025FY-5.830-5.600-5.830673664.69
2026FY--1.585--750.46
2027FY-0.204--978.93
2028FY-0.437--1,095
2029FY-1.187--1,201
2030FY-2.173--1,399

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0717123226.63204239
2026Q4S2026-11-0517133226.63204239
2026Q4S2026-11-0417132227.41204251.17
2026Q4S2026-11-031773219.67191251.17
2026Q4S2026-11-021773219.67191251.17
2026Q4S2026-10-211783219.67191251.17
2026Q4S2026-10-191773219.28191251.17
2026Q4S2026-10-161785219.28191251.17
2026Q4S2026-10-131794220.54191251.17
2026Q4S2026-10-121694221.39191251.17
2026Q4S2026-10-0716103221.93191251.17
2026Q4S2026-10-0616112223.17191251.17
2026Q4S2026-09-2316103223.02191251.17
2026Q4S2026-09-1816104223.02191251.17

Estimate history

EPS, annual-7.12-3.97-7.118-3.066-6.697-10.118-8.249-6.287-5.832-5.1888
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.398-1.394-1.569-1.168-1.808-1.291-1.839-0.903-1.156
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2.61251.495103.714271.03351.406363.329434.249560.23673730
Period201720182019202020212022202320242025TTM
Sales, quarterly139.494164.877139.292166.496159.933207136214173
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual44.16750.86157.83866.81969.34570.19782.30692.41596.4101.9
Period201720182019202020212022202320242025MRQ
Shares, quarterly92.23592.41593.74196.18196.26996.49898.3101.9
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue730.00673.00560.23434.25363.33351.41271.03103.7151.49
Cost of Goods Sold Incl. D&A158.78136.00106.7767.4243.3229.2518.3917.5520.68
Gross Profit571.22537.00453.46366.83320.01322.16252.6486.1730.81
Selling, General and Administrative Excl. Other1,039.211,072.00989.43936.04968.93703.90569.56510.34402.18
Research and Development677.22723.00667.82626.24690.79483.91398.68357.36294.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-468.00-535.00-535.97-569.21-648.92-381.74-316.92-424.17-371.37
Interest Expense82.0062.0063.0466.0043.0229.4233.291.140.00
Unusual Expense0.000.001.11-0.4019.3042.06-157.20-13.410.00
Net Income Before Taxes-530.00-571.00-567.59-608.46-701.73-452.98-185.36-399.44-197.10
Income Taxes-6.004.001.60-1.825.701.041.213.280.51
Consolidated Net Income-524.00-575.00-569.18-606.64-707.42-454.02-186.57-402.73-197.61
Net Income From Continuing Operations-524.00-575.00-569.18-606.64-707.42-454.02-186.57-402.73-197.61
Net Income-524.00-575.00-569.18-606.64-707.42-454.02-186.57-402.73-197.61
EPS (Recurring)-5.13-5.83-6.28-8.25-9.93-6.26-4.87-7.28-3.97
EPS (Basic, Before Extraordinaries)-5.19-5.83-6.29-8.25-10.12-6.70-3.07-7.12-3.97
EPS (Diluted)-5.19-5.83-6.29-8.25-10.12-6.70-3.07-7.12-3.97
EBITDA-434.21-500.00-500.43-543.20-630.72-368.50-304.65-415.63-351.83
Non-Operating Income (Expense)20.0026.0032.5426.359.510.247.6412.45174.28
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense107.44120.87124.86106.82102.9976.6362.5959.8663.28
Price To Sales Ratio2.103.376.808.108.9216.2231.0823.3042.03
Gross Margin78.2579.7980.9484.4888.0891.6893.2183.0859.83
Operating Margin-64.11-79.49-95.67-131.08-178.60-108.63-116.93-408.98-721.18
Net Margin-71.78-85.44-101.60-139.70-194.71-129.20-68.84-388.31-383.75
Shares Outstanding101.9096.4092.4182.3170.2069.3466.8257.8450.86
Market Capitalization1,645.051,645.053,884.923,926.713,247.995,731.769,157.952,467.402,199.22

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue173.00214.00136.00207.00159.93166.50139.29164.88
Cost of Goods Sold Incl. D&A41.0042.0038.0037.7836.6031.6237.6525.97
Gross Profit132.00172.0098.00169.22123.34134.88101.64138.90
Selling, General and Administrative Excl. Other242.00247.00267.00283.21294.23242.76244.58261.18
Research and Development145.00159.00179.00194.22207.61156.12156.78178.69
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-110.00-75.00-169.00-114.00-170.89-107.89-142.94-122.28
Interest Expense20.0022.0021.0019.0014.1514.0414.3415.52
Unusual Expense0.000.000.000.00-0.680.010.161.55
Net Income Before Taxes-127.00-91.00-184.00-128.00-179.54-114.00-149.77-133.40
Income Taxes-9.001.001.001.000.870.951.31-0.02
Consolidated Net Income-118.00-92.00-185.00-129.00-180.41-114.95-151.08-133.38
Net Income From Continuing Operations-118.00-92.00-185.00-129.00-180.41-114.95-151.08-133.38
Net Income-118.00-92.00-185.00-129.00-180.41-114.95-151.08-133.38
EPS (Recurring)-1.16-0.90-1.84-1.29-1.81-1.17-1.57-1.38
EPS (Basic, Before Extraordinaries)-1.16-0.90-1.84-1.29-1.81-1.17-1.57-1.39
EPS (Diluted)-1.16-0.90-1.84-1.29-1.81-1.17-1.57-1.39
EBITDA-101.00-67.00-161.00-105.22-162.28-99.27-133.95-113.20
Non-Operating Income (Expense)3.006.006.005.004.827.937.675.94
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense26.8626.8623.7030.0229.2430.5131.5331.75
Price To Sales Ratio2.104.753.153.424.765.875.907.19
Gross Margin76.3080.3772.0681.7577.1281.0172.9784.25
Operating Margin-63.58-35.05-124.26-55.07-106.85-64.80-102.62-74.16
Net Margin-68.21-42.99-136.03-62.32-112.81-69.04-108.46-80.90
Shares Outstanding101.9098.3098.0096.4096.2796.1893.7492.41
Market Capitalization1,645.053,288.552,024.392,218.982,898.863,437.553,349.463,884.92

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments693.00616.83579.22748.62740.201,212.38755.39459.98234.95
Short Term Receivables159.00123.6074.4946.8444.4349.0932.8412.745.17
Inventories52.0045.0133.9726.7716.2313.0511.557.070.76
Other Current Assets47.0031.6844.5161.6655.7420.7851.2442.5928.70
Total Current Assets951.00817.12732.18883.90856.601,295.30851.02522.37269.58
Net Property, Plant & Equipment267.00291.43314.47285.69176.18114.0474.6820.0521.84
Total Investments and Advances59.00138.63203.71158.30295.86169.7035.421.8212.07
Long-Term Note Receivable----0.500.20---
Intangible Assets220.00222.72210.68204.51175.19175.52173.41173.63185.95
Deferred Tax Assets--5.966.148.9433.357.66--
Other Assets35.0033.5629.9813.0518.064.790.971.691.31
Total Assets1,532.001,503.461,496.971,551.591,531.341,792.901,143.16719.56490.75
Short Term Debt Incl. Current Port. of LT Debt81.0060.1441.8411.7811.078.987.240.000.00
Accounts Payable31.0038.7642.1143.2717.1412.9212.8712.288.89
Other Current Liabilities272.00245.25196.49206.16153.16167.7183.1962.4562.13
Total Current Liabilities384.00344.15280.44261.21181.37189.61103.3074.7271.01
Long Term Debt1,171.00849.87892.90895.25382.69374.92345.130.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities30.0030.0636.0237.8142.2566.6540.9731.1731.17
Other Liabilities20.0017.0812.214.822.477.350.004.765.12
Total Liabilities1,605.001,241.161,221.561,199.09608.78638.53489.39110.65107.30
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-80.00255.30275.41352.49922.561,154.38653.76608.91383.45
Total Shareholders Equity-80.00255.30275.41352.49922.561,154.38653.76608.91383.45
Accumulated Minority Interest7.007.000.000.000.000.000.000.000.00
Total Equity-73.00262.30275.41352.49922.561,154.38653.76608.91383.45
Total Liabilities & Stockholders Equity1,532.001,503.461,496.971,551.591,531.341,792.901,143.16719.56490.75
Book Value Per Share-0.832.763.355.0213.3017.2811.3011.978.68
Tangible Book Value Per Share-3.110.350.792.1110.7814.658.318.564.47
Full-Time Employees1,3711,2941,2761,3111,119893740610520
Price to Book Ratio-4.3711.19108.836.936.328.013.783.635.39
Return on Assets-37.89-37.94-39.80-45.89-27.32-12.71-43.24-32.65-58.59
Return on Equity-656.03-214.50-193.23-110.96-43.72-20.64-63.79-39.83-70.48
Return on Invested Capital-52.70-51.50-51.92-56.70-34.78-12.20-40.32-32.45-78.79
Quick Ratio2.342.242.493.284.636.768.136.903.79
Current Ratio2.482.372.613.384.726.838.246.993.80

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-523.56-575.00-569.18-606.64-707.42-454.02-186.57-402.73-197.61
Depreciation33.7835.0035.5426.0118.2213.2412.268.5419.54
Other Funds (Non Cash)96.3597.00105.53120.93248.50165.33-62.5864.75-87.70
Funds from Operations-403.42-443.00-428.11-461.32-442.34-275.46-236.88-327.30-265.78
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-33.41-23.0013.92-13.4861.87-63.24104.66-18.08-24.79
Cash from Operating Activities-436.83-466.00-414.19-474.81-380.46-338.69-132.22-345.38-290.57
Capital Expenditures-9.94-21.00-19.99-46.77-146.12-73.09-43.91-24.83-4.08
Net Assets From Acquisitions0.000.000.000.00-75.030.000.000.000.00
Sale of Fixed Assets and Businesses0.000.007.000.000.000.000.000.00-
Purchase or Sale of Investments-7.58258.004.66219.81-69.66-121.34-129.6611.79-199.58
Purchase of Investments-380.56-186.00-408.61-526.38-614.74-1,012.19-850.30-707.16-509.80
Sale Or Maturity of Investments372.97444.00413.27746.20545.08890.85720.64718.96310.22
Other Uses-1.73-1.00-2.44-5.05-0.84-0.94-5.550.000.00
Other Sources-0.000.000.000.000.000.000.00170.32
Cash from Investing Activities-19.25236.00-10.77168.00-291.65-195.37-179.12-13.04-33.33
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock15.1986.00392.24388.1710.81119.04600.51365.07336.85
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock15.1986.00392.24388.1710.81119.04600.51365.07336.85
Proceedsfrom Stock Options13.2780.00380.98379.750.0078.94511.21355.24309.02
Issuance or Reduction of Debt, Net392.00392.000.000.00490.950.000.00314.230.00
Change in Long Term Debt392.00392.000.000.00490.950.000.00314.230.00
Issuance of Long Term Debt392.00392.000.000.00490.950.000.00314.230.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.00-0.03-0.56-0.49-0.240.000.00
Other Financing Activities Uses0.000.000.00-0.03-0.56-0.49-0.240.000.00
Cash from Financing Activities407.19478.00392.24388.14501.21118.55600.27679.31336.85
Exchange Rate Effect-1.664.00-2.520.46-1.07-1.191.12-0.17-0.47
Net Change in Cash-50.54252.00-35.2481.80-171.98-416.71290.05320.7212.48
Free Cash Flow-441.77-472.00-421.68-519.07-496.59-411.79-176.12-370.21-294.64
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.00-1.62-1.640.000.002.140.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments274.00301.00421.00693.00435.07496.62
Short Term Receivables166.00200.00121.00159.00114.64125.36
Inventories59.0059.0055.0052.0052.2046.50
Other Current Assets45.0046.0060.0047.0041.2951.31
Total Current Assets544.00606.00657.00951.00643.21719.79
Net Property, Plant & Equipment231.00235.00239.00267.00249.96255.76
Total Investments and Advances141.00150.00127.0059.0024.4354.76
Intangible Assets214.00216.00218.00220.00217.35219.14
Other Assets57.0057.0055.0035.0055.5056.82
Total Assets1,187.001,264.001,296.001,532.001,190.441,306.27
Short Term Debt Incl. Current Port. of LT Debt80.0076.0072.0081.0077.6975.63
Accounts Payable45.0039.0042.0031.0040.5734.24
Other Current Liabilities264.00236.00211.00272.00221.76183.37
Total Current Liabilities389.00351.00325.00384.00340.02293.24
Long Term Debt1,106.001,126.001,128.001,171.00785.43807.28
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities21.0030.0030.0030.0030.0630.06
Other Liabilities40.0041.0042.0020.0018.7817.40
Total Liabilities1,556.001,548.001,525.001,605.001,174.291,147.98
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-376.00-291.00-236.00-80.009.16151.29
Total Shareholders Equity-376.00-291.00-236.00-80.009.16151.29
Accumulated Minority Interest7.007.007.007.007.007.00
Total Equity-369.00-284.00-229.00-73.0016.16158.29
Total Liabilities & Stockholders Equity1,187.001,264.001,296.001,532.001,190.441,306.27
Book Value Per Share-3.69-2.96-2.41-0.830.101.57
Tangible Book Value Per Share-5.79-5.16-4.63-3.11-2.16-0.71
Full-Time Employees---1,371--
Price to Book Ratio-4.37-13.87-25.24241.7519.1223.63
Return on Assets-44.08-45.63-46.73-37.91-42.50-36.44
Return on Equity----656.54-325.76-182.60
Return on Invested Capital-16.16-11.02-20.74-11.82-22.71-11.99
Quick Ratio1.251.561.852.341.742.30
Current Ratio1.401.732.022.481.892.45

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-118.00-92.00-185.00-128.56-180.41-114.95
Depreciation9.008.008.008.798.618.62
Other Funds (Non Cash)30.0016.0031.0019.3525.5219.87
Funds from Operations-89.00-68.00-146.00-100.42-146.28-86.46
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital46.00-29.00-51.000.5954.86-21.81
Cash from Operating Activities-43.00-97.00-197.00-99.83-91.42-108.27
Capital Expenditures-2.00-1.00-6.00-0.94-1.28-2.46
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments59.0048.00-43.00-71.58118.6473.94
Purchase of Investments-39.00-57.00-131.00-153.56-16.94-15.50
Sale Or Maturity of Investments98.00105.0088.0081.97135.5989.45
Other Uses1.00-3.000.000.27-0.18-0.31
Other Sources-0.000.000.000.000.00
Cash from Investing Activities58.0044.00-49.00-72.25117.1871.17
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock10.003.000.002.190.0083.65
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock10.003.000.002.190.0083.65
Proceedsfrom Stock Options10.003.000.000.270.0079.73
Issuance or Reduction of Debt, Net0.000.000.00392.000.000.00
Change in Long Term Debt0.000.000.00392.000.000.00
Issuance of Long Term Debt0.000.000.00392.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities10.003.000.00394.190.0083.65
Exchange Rate Effect-1.001.00-1.00-0.660.292.91
Net Change in Cash24.00-49.00-247.00221.4626.0549.47
Free Cash Flow-45.00-98.00-198.00-100.77-92.70-110.73

Revenue breakdown

Product2024: 285.00M 2025: 369.00M
Royalty2024: 275.00M 2025: 304.00M
Asia Pacific2024: 9.00M 2025: 18.00M
EMEA2024: 80.00M 2025: 108.00M
Latin America2024: 131.00M 2025: 170.00M
North America2024: 340.00M 2025: 377.00M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3025.33%23.6M93.3M4.17M
2026-10-1522.34%20.1M90.2M4.00M
2026-09-3022.56%20.3M90.2M3.69M
2026-09-1518.43%16.6M89.9M3.31M
2026-08-3119.07%17.1M89.9M2.34M
2026-08-1417.67%15.9M89.9M2.24M
2026-07-3116.67%15.0M89.8M2.18M
2026-07-1514.98%13.4M89.7M2.16M
2026-06-3018.09%16.2M89.7M2.13M
2026-06-1515.97%14.3M89.6M1.79M
2026-05-2916.40%14.7M89.7M1.87M
2026-05-1515.59%14.0M89.7M1.93M
2026-04-3014.73%13.7M92.8M2.07M
2026-04-1513.02%12.1M92.9M2.20M
2026-03-3112.50%11.4M91.3M2.47M
2026-03-1310.88%9.9M91.3M2.81M
2026-02-2710.51%9.6M91.3M2.68M
2026-02-1310.80%9.9M91.3M2.59M
2026-01-3010.13%9.1M89.8M2.42M
2026-01-159.87%8.9M89.8M2.22M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call5.009.6012.1011.1513.3751.002.000.988-0.0810.000
call6.009.8011.109.8711.4421.002.000.945-0.4240.001
call7.008.9010.108.949.9814.003.000.936-0.4180.002
call8.008.009.207.939.2155.002.000.925-0.4100.002
call9.007.108.307.537.41234.003.000.913-0.3990.002
call9.506.707.507.086.32434.006.000.906-0.3920.002
call10.006.207.106.446.3944.007.000.899-0.3850.002
call10.505.706.605.955.9214.004.000.891-0.3770.002
call11.004.906.205.355.9031.002.000.883-0.3680.002
call11.504.705.504.904.6650.002.000.873-0.3580.003
call12.004.005.100.004.6080.000.000.842-0.4360.003
call12.503.604.700.003.7990.000.000.829-0.4220.003
call13.001.605.202.845.10910.000.000.814-0.4040.003
call13.502.703.602.403.46510.000.000.797-0.3880.003
call14.000.604.301.974.39219.000.000.779-0.3710.004
call14.501.152.550.002.5170.000.000.727-0.4590.004
call15.000.053.301.003.43217.000.000.698-0.4210.004
call15.500.751.401.101.2683.003.000.674-0.3610.004
call16.000.300.950.151.07783.006.000.633-0.2870.005
call16.500.250.500.280.80133.003.000.566-0.2130.005
call17.000.050.250.200.77329.000.000.495-0.3010.005
call17.500.000.700.101.13525.000.000.401-0.2450.005
call18.000.001.050.071.49021.000.000.286-0.1870.004
call18.500.001.650.191.7232.000.000.221-0.1610.004
call19.000.002.100.001.9750.000.000.200-0.1730.003
call19.500.002.100.002.1820.000.000.186-0.1850.003
call20.000.000.500.002.4880.000.000.169-0.1940.003
call20.500.000.500.002.6180.000.000.162-0.2030.003
call21.000.000.550.002.2170.000.000.086-0.1090.002
call21.500.000.500.003.0680.000.000.144-0.2150.003
call22.000.000.500.003.2450.000.000.139-0.2210.003
call22.500.000.500.003.3940.000.000.134-0.2270.003
call23.000.000.500.003.5210.000.000.130-0.2350.003
call23.500.000.500.003.7330.000.000.125-0.2370.002
call24.000.000.700.003.8840.000.000.121-0.2420.002
call24.500.000.550.004.0310.000.000.118-0.2460.002
call25.000.000.550.004.1580.000.000.115-0.2500.002
call25.500.000.500.004.2960.000.000.112-0.2540.002
call26.000.000.500.004.4310.000.000.110-0.2570.002
call26.500.001.700.004.5590.000.000.107-0.2610.002
call27.000.000.900.004.7040.000.000.105-0.2650.002
call27.500.002.100.004.7920.000.000.103-0.2680.002
put5.000.000.050.006.8490.000.00-0.012-0.0540.000
put6.000.001.700.0012.1210.000.00-0.055-0.4220.001
put7.000.001.150.0010.5680.000.00-0.064-0.4190.002
put8.000.001.700.008.9890.000.00-0.076-0.3980.002
put9.000.001.850.007.8270.000.00-0.088-0.3880.002
put9.500.000.950.007.4410.000.00-0.093-0.3930.002
put10.000.001.700.006.7620.000.00-0.102-0.3740.002
put10.500.000.700.006.2350.000.00-0.111-0.3640.002
put11.000.000.500.005.6530.000.00-0.121-0.3450.002
put11.500.000.500.005.2000.000.00-0.131-0.3360.003
put12.000.001.200.005.5640.000.00-0.161-0.4200.003
put12.500.000.700.005.2390.000.00-0.171-0.4180.003
put13.000.001.250.004.8230.000.00-0.185-0.4070.003
put13.500.001.250.004.3760.000.00-0.201-0.3890.003
put14.000.000.700.053.8962.000.00-0.223-0.3650.004
put14.500.001.100.004.1960.000.00-0.281-0.4370.004
put15.000.001.850.153.81813.000.00-0.304-0.4160.004
put15.500.001.850.283.3379.000.00-0.331-0.3360.004
put16.000.001.700.502.8043.000.00-0.381-0.2740.005
put16.500.051.050.002.4280.000.00-0.430-0.2130.005
put17.000.052.401.344.6751.000.00-0.502-0.3030.005
put17.500.652.600.004.4280.000.00-0.599-0.2420.005
put18.000.453.200.005.0520.000.00-0.682-0.2090.004
put18.500.303.900.004.5440.000.00-0.777-0.1590.004
put19.000.754.400.003.7640.000.00-0.799-0.1720.003
put19.502.453.300.002.8310.000.00-0.815-0.1830.003
put20.001.755.400.006.6980.000.00-0.827-0.1930.003
put20.502.255.900.006.9730.000.00-0.838-0.2010.003
put21.002.706.400.007.2340.000.00-0.846-0.2090.003
put21.503.206.900.007.0350.000.00-0.854-0.2160.003
put22.003.807.400.006.2590.000.00-0.859-0.2220.003
put22.505.206.700.005.2530.000.00-0.865-0.2280.003
put23.004.808.400.008.1120.000.00-0.870-0.2320.003
put23.505.808.700.006.9470.000.00-0.811-0.3740.003
put24.006.109.200.005.9460.000.00-0.815-0.3820.003
put24.507.408.300.004.8900.000.00-0.881-0.2470.002
put25.007.209.008.375.0500.002.00-0.884-0.2520.002
put25.508.409.308.825.2050.002.00-0.887-0.2560.002
put26.008.9010.2010.236.5130.000.00-0.890-0.2590.002
put26.509.4010.7010.306.7170.001.00-0.892-0.2630.002
put27.009.8011.3010.597.9050.002.00-0.894-0.2670.002
put27.509.6012.6011.049.8910.001.00-0.896-0.2700.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-10-30SEC
2026-10-30SCHEDULE 13G/ASEC
2026-10-20SCHEDULE 13GSEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-198-KCurrent report2026-10-19SEC
2026-10-148-KCurrent report2026-10-08SEC
2026-10-078-KCurrent report2026-10-06SEC
2026-09-178-KCurrent report2026-09-17SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-028-KCurrent report2026-09-02SEC
2026-08-198-KCurrent report2026-08-19SEC
2026-08-14SCHEDULE 13GSEC
2026-08-13SCHEDULE 13GSEC
2026-08-118-KCurrent report2026-08-07SEC
2026-08-07SCHEDULE 13GSEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-03144Filing for proposed sale of securities under Rule 144.SEC
2026-07-31SCHEDULE 13G/ASEC
2026-07-31SCHEDULE 13GSEC
2026-07-30SCHEDULE 13G/ASEC
2026-07-064Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-01144Filing for proposed sale of securities under Rule 144.SEC
2026-06-15144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1000107.90K1
2026-090019.66K2
2026-0800164.37K2
2026-0700155.64K1
2026-0600207.46K3
2026-0500269.38K3
2026-040098.20K1
2026-03002.53M10
2026-020072.12K1
2026-010071.95K1
2025-1200115.01K2
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.10.82%
RTW INVESTMENTS, LP7.92%
VANGUARD PORTFOLIO MANAGEMENT LLC6.89%
AQR CAPITAL MANAGEMENT LLC6.66%
STATE STREET CORP6.25%
VANGUARD CAPITAL MANAGEMENT LLC4.36%
TWO SIGMA INVESTMENTS, LP3.68%
SANDS CAPITAL MANAGEMENT, LLC3.21%
JACOBS LEVY EQUITY MANAGEMENT, INC2.98%
FRONTIER CAPITAL MANAGEMENT CO LLC2.89%

Funds

Fund% owned
State Street(R) SPDR(R) S&P(R) Biotech ETF3.72%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.03%
iShares Russell 2000 ETF2.54%
VANGUARD SMALL-CAP INDEX FUND2.18%
VANGUARD SMALL-CAP GROWTH INDEX FUND1.26%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
VANGUARD STRATEGIC EQUITY FUND1.09%
Fidelity Small Cap Index Fund1.07%
AQR Long-Short Equity Fund0.93%
VANGUARD EXPLORER FUND0.83%

OakChart. RARE. Cached 15 minutes.